The association between XPA polymorphisms with HCC risk is biologically plausible since XPA plays an important role in NER pathway while XPA protein defects were previously shown to lead to HCC susceptibility in mouse model experiments [6]. This evidence concerns the gene XPA and hepatocellular carcinoma.